PCR164 Development and Validation of the Symptom Assessment for Bronchiectasis (SABRE) for the FDA Qualification Program: A Novel Patient-Reported Outcome Instrument to Measure Symptoms of Non-Cystic Fibrosis Bronchiectasis
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.1483
https://www.valueinhealthjournal.com/article/S1098-3015(25)01608-0/fulltext
Title :
PCR164 Development and Validation of the Symptom Assessment for Bronchiectasis (SABRE) for the FDA Qualification Program: A Novel Patient-Reported Outcome Instrument to Measure Symptoms of Non-Cystic Fibrosis Bronchiectasis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)01608-0&doi=10.1016/j.jval.2025.04.1483
First page :
Section Title :
Open access? :
No
Section Order :
11172